Client News

Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management

Secarna Pharmaceuticals and Orbit Discovery Enter Collaboration to Discover and Develop Peptide-Conjugated Targeted Antisense Oligonucleotide Therapeutics

Medigene AG Expands its End-to-End Platform by Submitting Three Patents to the European Patent Office

Syntekabio to Showcase Advanced AI Drug Discovery Technologies at BIO International Convention 2024

InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators

Medigene’s Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announced Term

Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for its Planned FDA Trial

Volta Medical Presents Results from First Transatlantic Randomized Controlled Trial Comparing AI-Assisted Ablation Procedure with Conventional Treatment for Persistent Atrial Fibrillation Patients

Integrated DNA Technologies and Molecular Health Ink Commercial Partnership

Medigene AG Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS